Gastric Cancer: From Silent Killer to Treatable Disease in 2026
Breakthroughs in early detection and treatment are transforming gastric cancer outcomes across Asia in 2026, say leading medical experts.
MedicalAdvancements
Breakthrough ALS Drug Tofersen Launches in China, Offering New Hope
Tofersen, a gene-targeted therapy for ALS caused by SOD1 mutations, is now available in China, offering hope for slowing disease progression.